Triclabendazole
Kathryn Dzintars, PharmD, BCPS, Paul G. Auwaerter, M.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
Triclabendazole was approved in 2019 for treating fasciola in individuals ≥ 6 years.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.